Inactive Instrument

Cantel Medical Corp.

Equities

CMD

US1380981084

Medical Equipment, Supplies & Distribution

Cantel Medical Corp. Provides Revenue Guidance for the Third Quarter of 2020; Withdraws Earnings Guidance for the Fiscal Year 2020

May 12, 2020 at 07:30 am EDT

Cantel Medical Corp. provided revenue guidance for the third quarter of 2020. Revenue for the third quarter is estimated at $235 to $237 million, down approximately 18% sequentially vs. the prior quarter.

Given the significant uncertainty related to the COVID pandemic, the company is also withdrawing its financial guidance for fiscal year 2020.

Latest news about Cantel Medical Corp.

Evoqua Water Technologies Ltd and Evoqua Water Technologies LLC completed the acquisition of Renal Business from Cantel Medical LLC.	22-01-02	CI
Evoqua Water Technologies Ltd and Evoqua Water Technologies LLC entered into a definitive agreement to acquire Renal Business from Cantel Medical LLC for approximately $200 million.	21-12-19	CI
Azek : Hires Peter Clifford for CFO Role	21-07-19	MT
Cantel Medical Corp. Announces Board Changes	21-06-08	CI
Cantel Medical Corp.(NYSE:CMD) dropped from S&P 1000	21-06-02	CI
Cantel Medical Corp.(NYSE:CMD) dropped from S&P Composite 1500	21-06-02	CI
Cantel Medical Corp.(NYSE:CMD) dropped from S&P Healthcare Equipment Select Industry Index	21-06-02	CI
Cantel Medical Corp.(NYSE:CMD) dropped from S&P 400 Health Care	21-06-02	CI
Cantel Medical Corp.(NYSE:CMD) dropped from S&P 400	21-06-02	CI
Cantel Medical Corp.(NYSE:CMD) dropped from S&P Global BMI Index	21-06-02	CI
Cantel Medical Corp.(NYSE:CMD) dropped from S&P TMI Index	21-06-02	CI
STERIS plc completed the acquisition of Cantel Medical Corp. from Charles M. Diker, Mark N. Diker, Diker Management LLC, Champlain Investment Partners, LLC, Brown Capital Management, LLC and others.	21-06-01	CI
Cantel Medical Corp. Reports Earnings Results for the Third Quarter Ended April 30, 2021	21-05-28	CI
Crocs : to Replace Cantel Medical in S&P MidCap 400, Organogenesis Moves to S&P SmallCap 600	21-05-27	MT
STERIS : Needham Upgrades STERIS to Buy From Hold, Citing Cantel Medical Deal; Sets $233 Price Target	21-05-26	MT
Steris : Positioned to Beat FY22 Estimates on Conservative Guidance After Q4 Shortfall, Says Needham	21-05-19	MT
Steris : Poised to see Stable Revenue Growth of 4%-6% in Fiscal 2022, Needham says	21-05-19	MT
STERIS : Sees Higher Fiscal 2021 Revenue	21-04-27	MT
Cantel Medical : Fiscal Q2 Results Lead Needham to Raise EPS, Revenue Estimates	21-03-09	MT
Transcript : Cantel Medical Corp., Q2 2021 Earnings Call, Mar 09, 2021	21-03-09
Cantel Medical : Fiscal Q2 Adjusted Earnings, Revenue Rise	21-03-09	MT
STERIS : Earnings Flash (STE) CANTEL MEDICAL Reports Q2 Revenue $294M, vs. Street Est of $276.6M	21-03-09	MT
STERIS : Earnings Flash (STE) CANTEL MEDICAL Posts Q2 EPS $0.79, vs. Street Est of $0.50	21-03-09	MT
Cantel Medical Corp. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended January 31, 2021	21-03-08	CI
CANTEL MEDICAL : Needham Downgrades Cantel Medical to Hold From Buy	21-01-13	MT

Chart Cantel Medical Corp.

Duration

Period

More charts

Company Profile

Cantel Medical LLC is a United States-based company that provides infection prevention solutions. The Company provides infection prevention products and services for patients, caregivers and other healthcare providers. Its operates through three primary segments, such as Medical, Dental and Life Sciences.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Medical Equipment Wholesale

	1st Jan change	Capi.
HENRY SCHEIN, INC.	-3.88%	9.36B
SHIP HEALTHCARE HOLDINGS, INC.	+1.25%	1.49B
OWENS & MINOR, INC.	+2.65%	1.43B
AS ONE CORPORATION	-4.57%	1.21B
GKHT MEDICAL TECHNOLOGY CO., LTD.	-16.13%	877M
TOKAI CORP.	+1.44%	482M
GAUSH MEDITECH LTD	-47.14%	374M
COWEALTH MEDICAL CHINA CO.,LTD.	-20.99%	346M
WIN-PARTNERS CO., LTD.	-2.68%	213M

Medical Equipment Wholesale